Lobbying client
OSRX, INC.
OSRX is a 503A compunding pharmacy.
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
7
Filed by
2
Reported in-house
—
Reported by firms
$300,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2019 to 2026
Filings
7 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
3rd Quarter - Termination 3rd Quarter 2026
|
BAKER & HOSTETLER LLP | $90,000 reported |
|
2nd Quarter - Report 2nd Quarter 2026
|
BAKER & HOSTETLER LLP | $70,000 reported |
|
1st Quarter - Report 1st Quarter 2026
|
BAKER & HOSTETLER LLP | $70,000 reported |
|
4th Quarter - Report 4th Quarter 2025
|
BAKER & HOSTETLER LLP | $70,000 reported |
|
Registration 4th Quarter 2025
|
BAKER & HOSTETLER LLP | — reported |
|
3rd Quarter - Termination 3rd Quarter 2019
|
MS. TAMI WAHL | — reported |
|
Registration 3rd Quarter 2019
|
MS. TAMI WAHL | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| BAKER & HOSTETLER LLP | 4 | $300,000 |
| MS. TAMI WAHL | 1 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 7 |
| Pharmacy | PHA | 2 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.